Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd.verified

SCNI

Price:

$0.331

Market Cap:

$435.39K

Scinai Immunotherapeutics Ltd. operates as an emerging biopharmaceutical company, dedicated to the research, production, and market introduction of medical solutions. Based in Israel, its primary objective is the prevention and treatment of a range of infectious, autoimmune, and other health conditions. The company maintains a significant licensing and collaboration agreement with the Max Planck Society and the University Medical Center Göttingen. This partnership is focused on advancing and commercializing a nanosized antibody (NanoAb) specifically for COVID-19, in addition to pursuing NanoAb applications for various other disease indications. Established in 2003, the company was formerly k...[Read more]

Industry

Biotechnology

IPO Date

2015-05-11

Stock Exchange

NASDAQ

Ticker

SCNI

The Current Ratio as of June 2026 (TTM) for Scinai Immunotherapeutics Ltd. (SCNI) is 1.35

According to Scinai Immunotherapeutics Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.35. This represents a change of 60.61% compared to the average of 0.84 of the last 4 quarters.

Scinai Immunotherapeutics Ltd. (SCNI) Historical Current Ratio (quarterly & annually)

How has SCNI Current Ratio performed in the past?

The mean historical Current Ratio of Scinai Immunotherapeutics Ltd. over the last ten years is 5.66. The current 1.35 Current Ratio has changed 2.28% with respect to the historical average. Over the past ten years (40 quarters), SCNI's Current Ratio was at its highest in in the March 2017 quarter at 31.16. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

5.66

Median

3.69

Minimum

0.17

Maximum

19.01

Scinai Immunotherapeutics Ltd. (SCNI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Scinai Immunotherapeutics Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 4.31%

Maximum Annual Current Ratio = 19.01

Minimum Annual Increase = -95.71%

Minimum Annual Current Ratio = 0.17

Quarterly (TTM)
Annual
YearCurrent RatioChange
20251.30-2.12%
20241.32-56.74%
20233.06-50.21%
20226.15-15.81%
20217.304.31%
20200.17-95.71%
20193.869.41%
20183.53-67.78%
201710.94-42.45%
201619.01-12.54%

Scinai Immunotherapeutics Ltd. (SCNI) Average Current Ratio

How has SCNI Current Ratio performed in the past?

The current Current Ratio of Scinai Immunotherapeutics Ltd. (SCNI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.89

5-year avg

3.83

10-year avg

5.66

Scinai Immunotherapeutics Ltd. (SCNI) Current Ratio vs. Peers

How is SCNI’s Current Ratio compared to its peers?

Scinai Immunotherapeutics Ltd.’s Current Ratio is less than Onconetix, Inc. (1.41), less than SciSparc Ltd. (2.41), less than Azitra, Inc. (6.94), less than Indaptus Therapeutics, Inc. (2.34), greater than Silexion Therapeutics Ltd. (1.00), less than Salarius Pharmaceuticals, Inc. (1.84), less than Jasper Therapeutics, Inc. (2.26), less than Revelation Biosciences, Inc. (10.02), less than Psyence Biomedical Ltd. (11.04), less than Enveric Biosciences, Inc. (11.67),

Build a custom stock screener for Scinai Immunotherapeutics Ltd. (SCNI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Scinai Immunotherapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Scinai Immunotherapeutics Ltd. (SCNI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Scinai Immunotherapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Scinai Immunotherapeutics Ltd.'s Current Ratio?

How is the Current Ratio calculated for Scinai Immunotherapeutics Ltd. (SCNI)?

What is the highest Current Ratio for Scinai Immunotherapeutics Ltd. (SCNI)?

What is the 3-year average Current Ratio for Scinai Immunotherapeutics Ltd. (SCNI)?

What is the 5-year average Current Ratio for Scinai Immunotherapeutics Ltd. (SCNI)?

How does the current Current Ratio for Scinai Immunotherapeutics Ltd. (SCNI) compare to its historical average?